Hoping For A New Dawn In UK’s Value-Based Procurement
The UK’s MedTech Directorate is undergoing a partial relaunch, with a new director set to take the reins and a new strategy being finalized. The medtech industry hopes the renewed impetus will put long-overdue attention to value-based procurement for medtech goods.
You may also be interested in...
The UK government’s new procurement-and-beyond body housed in the DHSC says a medtech strategy could hit the presses before 2023. The medtech industry is cheered by promises of engagement.
In the three months since Brexit, UK medtech stakeholders have seen the beginnings of new regulations, foreign trade plans being put in place, and perhaps new perceptions of medtech’s value.
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.